2015 Fiscal Year Final Research Report
Development of the new molecular target therapy for phenytoin-induced gingival overgrowth using the antagonist of TRPA1 channel
| Project/Area Number |
25463180
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Orthodontics/Pediatric dentistry
|
|---|
| Research Institution | The University of Tokushima |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
MATSUMOTO Fumihiro 徳島大学, 病院, 講師 (70229566)
KITAMURA Takamasa 徳島大学, 大学院医歯薬学研究部, 助教 (50614020)
YAMAMOTO Aimi 徳島大学, 病院, 医員 (10630171)
UEDA Kimiko 徳島大学, 病院, 助教 (40335807)
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Keywords | 歯肉増殖症 / フェニトイン / p-HPPH / TRPA1 / メンソール / カンファ― / シネオール |
|---|
| Outline of Final Research Achievements |
For a purpose to determine a disease developing mechanism of gingival hyperplasia with the phenytoin, we examined the effect that metabolites (p-HPPH) of the phenytoin gave to human normal gingiva fibroblasts (HGF). As a result, p-HPPH was suggested to restrain the expression of collagen degrading enzyme (MMP-1) in HGF.
Then, we examined whether the inhibitor of the TRPA1 channel (HC030031) interfered restraint of the MMP-1 expression by p-HPPH to develop a therapeutic drug of gingival hyperplasia. As a result, the expression of mRNA of MMP-1 which decreased by administration of p-HPPH increased by the dosage of HC030031. As a result, we found that all materials have the effects similar to HC030031. Effect of Menthol was found to be the strongest in the three.
|
| Free Research Field |
障害者歯科
|
